Brookstone Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,643
| Closed | -$315K | – | 952 |
|
|
2024
Q1 | $315K | Buy |
+4,643
| New | +$315K | 0.01% | 749 |
|
|
2022
Q3 | – | Sell |
-33,363
| Closed | -$2.24M | – | 782 |
|
|
2022
Q2 | $2.24M | Buy |
33,363
+27,362
| +456% | +$1.83M | 0.05% | 270 |
|
|
2022
Q1 | $424K | Buy |
6,001
+2,368
| +65% | +$167K | 0.01% | 586 |
|
|
2021
Q4 | $209K | Sell |
3,633
-18
| -0.5% | -$1.04K | ﹤0.01% | 701 |
|
|
2021
Q3 | $221K | Sell |
3,651
-2,003
| -35% | -$121K | ﹤0.01% | 677 |
|
|
2021
Q2 | $343K | Buy |
+5,654
| New | +$343K | 0.01% | 554 |
|
|
2015
Q4 | – | Sell |
-100
| Closed | -$3K | – | 216 |
|
|
2015
Q3 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 1598 |
|